Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

1articles mentioning institutions

1institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: NCT04951219 ×

NCT04951219

This institution is selected. Its supporting articles are shown below.

NCT049512191

Articles mentioning NCT04951219

1 articles · page 1 of 1

P4 Treatment with resmetirom for up to two years led to improvement in liver stiffness, fibrosis biomarkers, fibrosis scores and portal hypertension risk in 122 patients with compensated MASH cirrhosis

gutjnl · abstract · 2025-10-06 · 1 matching annotations

77.1%

NCT04951219 Resmetirom MASH metabolic dysfunction-associated steatohepatitis NASH CSPH MASH cirrhosis

…ESTRO-NAFLD-1( NCT04197479) year 1; open-label extension trial (NCT04951219) (year 2)). Patients were assessed for baseline CSPH (Baveno VI…